PIPA5121813

KLK11 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5121813-Each-of-1 In Stock ₹ 14,756.20

PIPA5121813 - Each of 1

₹ 14,756.20

In Stock

Quantity

1

Base Price: ₹ 14,756.20

GST (18%): ₹ 2,656.116

Total Price: ₹ 17,412.316

Antigen

KLK11

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Klk11

Gene Alias

2310015I08Rik; Hippostasin; hK11; kallikrein 11; kallikrein related peptidase 11; kallikrein related-peptidase 11; Kallikrein11; kallikrein-11; Kallikrein-11 inactive chain 1; Kallikrein-11 inactive chain 2; kallikrein-related peptidase 11; KLK11; protease, serine, 20; Prss20; Serine protease 20; TLSP; Trypsin-like protease; UNQ649/PRO1279

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

11012

Content And Storage

-20°C

Form

Liquid

Applications

Immunohistochemistry (Paraffin), Western Blot

Concentration

500 μg/mL

Formulation

PBS with 50% glycerol and 0.05% ProClin 300

Gene Accession No.

Q9UBX7

Gene Symbols

Klk11

Immunogen

Recombinant protein Kallikrein 11. The antigen corresponds to amino acid range 39-282 of the target protein.

Quantity

20 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA5121621

--

Img

Thermo Scientific

PIPA5121819

--

Img

Thermo Scientific

PIPA5122175

--

Img

Thermo Scientific

PIPA5121980

--

Img

Thermo Scientific

PIPA5121689

--

Img

Thermo Scientific

PIPA5121623

--

Img

Thermo Scientific

PIPA5121624

--

Img

Thermo Scientific

PIPA5121739

--

Description

  • Hippostasin, also known as KLK11, is a kallikrein-like serine protease, which has two alternatively spliced isoforms, brain-type and prostate-type
  • Hippostasin plays a role in the prostate, including reproductive and/or tumorigenic functions
  • Elevated serum levels of KLK11 were found in 70% of women with ovarian cancer and in 60% of men with prostate cancer
  • Analysis of the KLK11 biomarker in serum may aid in the diagnosis and monitoring of ovarian and prostatic carcinoma.